Biotechnology / Pharmaceutical Services Outsourcing

Biotechnology / Pharmaceutical Services Outsourcing

Global Biotechnology / Pharmaceutical Services Outsourcing Market to Reach $102.2 Billion by 2030
The global market for Biotechnology / Pharmaceutical Services Outsourcing estimated at US$70.4 Billion in the year 2023, is expected to reach US$102.2 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Consulting Services, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$20.9 Billion by the end of the analysis period. Growth in the Regulatory Affairs Services segment is estimated at 6.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $18.9 Billion, While China is Forecast to Grow at 8.8% CAGR
The Biotechnology / Pharmaceutical Services Outsourcing market in the U.S. is estimated at US$18.9 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$22.7 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3% and 4.5% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$14.1 Billion by the year 2030.

Introducing Our Exciting New Report Features for 2024
» Full access to influencer engagement stats
» Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
» Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
» Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
» Complimentary report updates for one year
» Competitor coverage with global market shares of major players
» Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
» Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 46 Featured) -
  • ABmas
  • Acuitas Therapeutics
  • Advanced Rx Management
  • AmerisourceBergen Corporation
  • Aquaconeer
  • Archbow Consulting
  • Aummune
  • Avara Pharmaceutical Services, Inc.
  • Avior Bio, Inc.
  • Bionostra
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Biotechnology / Pharmaceutical Services Outsourcing – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing R&D Expenditure by Pharmaceutical Companies Driving Outsourcing Demand
Rising Focus on Cost Reduction and Efficiency Enhancement in Drug Development
Growth in Biopharmaceutical Production and Demand for Specialized Services
Technological Advancements in Drug Discovery, Development, and Manufacturing Processes
Expansion of Clinical Trials and Need for Regulatory Compliance Boosting CRO Market
Emergence of New Biologics and Biosimilars Creating Opportunities for CDMOs
Impact of Globalization and Strategic Partnerships on Outsourcing Market Dynamics
Increasing Complexity of Drug Molecules and Focus on Niche Therapeutics Driving Outsourcing
Adoption of Digital and Data-driven Solutions in Pharmaceutical Services Outsourcing
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Biotechnology / Pharmaceutical Services Outsourcing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Consulting Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Consulting Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Consulting Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Regulatory Affairs Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Regulatory Affairs Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Regulatory Affairs Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Auditing & Assessment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Auditing & Assessment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Auditing & Assessment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Product Design & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Product Design & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Product Design & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Product Testing & Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Product Testing & Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Product Testing & Validation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Product Maintenance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Product Maintenance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Product Maintenance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Training & Education by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Training & Education by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Training & Education by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Pharma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Pharma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Pharma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 33: World Historic Review for Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: World 16-Year Perspective for Biotech by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Biotechnology / Pharmaceutical Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 35: USA Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 38: USA Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: USA Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: USA 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
CANADA
TABLE 41: Canada Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: Canada Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Canada 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 44: Canada Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Canada 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
JAPAN
Biotechnology / Pharmaceutical Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 47: Japan Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Japan Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Japan 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 50: Japan Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Japan Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Japan 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
CHINA
Biotechnology / Pharmaceutical Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 53: China Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: China Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: China 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 56: China Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: China Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: China 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
EUROPE
Biotechnology / Pharmaceutical Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 59: Europe Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 60: Europe Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Europe 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 62: Europe Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Europe Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: Europe 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 65: Europe Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: Europe Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Europe 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
FRANCE
Biotechnology / Pharmaceutical Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 68: France Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: France Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: France 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 71: France Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: France Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: France 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
GERMANY
Biotechnology / Pharmaceutical Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 74: Germany Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Germany Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Germany 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 77: Germany Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Germany Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Germany 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
ITALY
TABLE 80: Italy Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Italy Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Italy 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 83: Italy Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Italy Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Italy 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
UNITED KINGDOM
Biotechnology / Pharmaceutical Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 86: UK Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: UK Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: UK 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 89: UK Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: UK Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: UK 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
SPAIN
TABLE 92: Spain Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Spain Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Spain 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 95: Spain Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Spain Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Spain 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
RUSSIA
TABLE 98: Russia Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Russia Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Russia 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 101: Russia Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Russia Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Russia 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Rest of Europe Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Rest of Europe 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Rest of Europe Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Rest of Europe 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Biotechnology / Pharmaceutical Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 111: Asia-Pacific Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: Asia-Pacific 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: Asia-Pacific Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: Asia-Pacific 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: Asia-Pacific Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: Asia-Pacific 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
AUSTRALIA
Biotechnology / Pharmaceutical Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 119: Australia Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: Australia Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: Australia 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 122: Australia Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Australia Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Australia 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
INDIA
Biotechnology / Pharmaceutical Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 125: India Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: India Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: India 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 128: India Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: India Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: India 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 131: South Korea Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: South Korea Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: South Korea 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 134: South Korea Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: South Korea Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: South Korea 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Rest of Asia-Pacific Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Rest of Asia-Pacific Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
LATIN AMERICA
Biotechnology / Pharmaceutical Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 143: Latin America Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 144: Latin America Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Latin America 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 146: Latin America Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Latin America Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Latin America 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 149: Latin America Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: Latin America Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Latin America 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 152: Argentina Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Argentina Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Argentina 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 155: Argentina Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Argentina Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Argentina 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
BRAZIL
TABLE 158: Brazil Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 159: Brazil Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Brazil 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 161: Brazil Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: Brazil Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: Brazil 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
MEXICO
TABLE 164: Mexico Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 165: Mexico Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: Mexico 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 167: Mexico Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: Mexico Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: Mexico 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: Rest of Latin America Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: Rest of Latin America 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: Rest of Latin America Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: Rest of Latin America 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
MIDDLE EAST
Biotechnology / Pharmaceutical Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 176: Middle East Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 177: Middle East Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: Middle East 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 179: Middle East Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: Middle East Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: Middle East 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 182: Middle East Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: Middle East Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: Middle East 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
IRAN
TABLE 185: Iran Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: Iran Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: Iran 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 188: Iran Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: Iran Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: Iran 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
ISRAEL
TABLE 191: Israel Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: Israel Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: Israel 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 194: Israel Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 195: Israel Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: Israel 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: Saudi Arabia Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Saudi Arabia 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: Saudi Arabia Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Saudi Arabia 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 203: UAE Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 204: UAE Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 205: UAE 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 206: UAE Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 207: UAE Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 208: UAE 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 210: Rest of Middle East Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 211: Rest of Middle East 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 213: Rest of Middle East Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 214: Rest of Middle East 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
AFRICA
Biotechnology / Pharmaceutical Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 215: Africa Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 216: Africa Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by Service - Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 217: Africa 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by Service - Percentage Breakdown of Value Sales for Consulting Services, Regulatory Affairs Services, Auditing & Assessment, Product Design & Development, Product Testing & Validation, Product Maintenance, Training & Education and Other Services for the Years 2014, 2024 & 2030
TABLE 218: Africa Recent Past, Current & Future Analysis for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 219: Africa Historic Review for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Pharma and Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 220: Africa 16-Year Perspective for Biotechnology / Pharmaceutical Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma and Biotech for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings